Chlamydia and Gonorrhea: Screening

1. Effectiveness of: different screening strategies for identifying persons who are at increased risk for infection, co-testing for concurrent STIs, and different screening intervals.
2. Effectiveness of screening asymptomatic men to reduce the consequences of infection and transmission to sexual partners.
3. Studies to identify subgroups (e.g., men who have sex with men, sexually active males younger than 24 years, men residing in high-prevalence communities) for whom screening may be effective.
4. Adverse effects of screening in any population.

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.

Chlamydia and Gonorrhea: Screening Read full statement 1